Clostridium difficile Infections (Clostridium difficile Associated Disease) Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Clostridium difficile Infections (Clostridium difficile Associated Disease) Global Clinical Trials Review, H1, 2019" provides an overview of Clostridium difficile Infections (Clostridium difficile Associated Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Clostridium difficile Infections (Clostridium difficile Associated Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Merck & Co Inc

Synthetic Biologics Inc

Sanofi

ICON Plc

Pfizer Inc

Astellas Pharma Inc

Johnson & Johnson

Seres Therapeutics Inc

Syneos Health Inc

Rebiotix ...

Merck & Co Inc

Synthetic Biologics Inc

Sanofi

ICON Plc

Pfizer Inc

Astellas Pharma Inc

Johnson & Johnson

Seres Therapeutics Inc

Syneos Health Inc

Rebiotix Inc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region ...

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 21

Clinical Trials by E7 Countries: Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials 23

Clinical Trials by Phase in E7 Countries 25

Clinical Trials in E7 Countries by Trial Status 26

Clinical Trials by Phase 28

In Progress Trials by Phase 29

Clinical Trials by Trial Status 30

Clinical Trials by End Point Status 32

Subjects Recruited Over a Period of Time 33

Clinical Trials by Sponsor Type 34

Prominent Sponsors 35

Top Companies Participating in Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials 37

Prominent Drugs 39

Latest Clinical Trials News on Clostridium difficile Infections (Clostridium difficile Associated Disease) 41

Mar 20, 2019: Microbiome Health Index Platform to be presented at Gut Microbiota for Health Summit 2019 41

Feb 27, 2019: Acurx announces first-in-man clinical trial data of ACX-362E for CDI 41

Feb 15, 2019: Summit begins dosing in Phase III trials of ridinilazole 42

Feb 11, 2019: Finch Therapeutics’ C. Difficile infection drug gets breakthrough status 42

Jan 31, 2019: Deinove is preparing initiation of Phase II for DNV3837 in Clostridium difficile infections, with a key partner 42

Jan 28, 2019: Oragenics receives further validation for lantibiotic compound OG716 43

Jan 24, 2019: MGB Biopharma - FDA and Health Canada clear IND/CTA applications for MGB-BP-3, a novel, potent bactericidal antibiotic targeting clostridium difficile-associated diarrhoea (CDAD) 43

Jan 22, 2019: Emory leads multi-site NIH clinical trial testing fecal transplants for recurrent diarrheal disease 44

Jan 16, 2019: Acurx receives FDA Fast Track Designation for ACX-362E for the treatment of C. difficile infection 44

Clinical Trial Profile Snapshots 46

Appendix 219

Abbreviations 219

Definitions 219

Research Methodology 220

Secondary Research 220

About GlobalData 221

Contact Us 221

Source 222

List of Tables

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical ...

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Region, 2019* 8

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, North America, Top Countries, 2019* 14

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16

Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 17

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 21

Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials, E7 Countries (%), 2019* 23

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 25

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 26

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Phase, 2019* 28

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 29

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 30

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 32

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 33

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 34

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 35

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 37

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 39

List of Figures

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, ...

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16

Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 17

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 21

Proportion of Clostridium difficile Infections (Clostridium difficile Associated Disease) to Infectious Disease Clinical Trials, E7 Countries (%), 2019* 23

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 25

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 26

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 28

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 29

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 30

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 32

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 33

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 34

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 35

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 37

Clostridium difficile Infections (Clostridium difficile Associated Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 39

GlobalData Methodology 220

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports